ReviewMolecular biology reports2026
The capping arms race: evolutionary interplay between IFIT proteins and viral molecular mimicry.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Effective host survival during viral infection depends on the ability to discriminate endogenous messenger RNA from pathogenic RNA species. Interferon-induced proteins with tetratricopeptide repeats (IFITs) constitute a central component of this defence system, functioning as specialised cytosolic RNA surveillance proteins that detect molecular features characteristic of non-self transcripts. This review examines the dynamic evolutionary interplay between IFIT-mediated antiviral restriction and viral evasion strategies. IFIT proteins recognise defined chemical and structural determinants at the RNA 5' terminus-including 5'-triphosphorylated ends and the absence of 2'-O-methylation-and sequester such transcripts to inhibit viral translation. In response, RNA viruses have evolved sophisticated evasion strategies, including the encoding or acquisition of 2'-O-methyltransferases, exploitation of host cap-modifying enzymes, and cap-snatching mechanisms that generate host-like cap 1 and m⁶Am signatures to evade immune recognition. Beyond the canonical antiviral roles attributed to IFIT1 and IFIT5, accumulating evidence indicates that IFIT2 and IFIT3 function as critical regulatory components within IFIT complexes, stabilising protein-protein interactions, modulating RNA-binding affinity, and influencing downstream signalling pathways. Collectively, these concepts position IFIT proteins as RNA surveillance proteins and regulatory scaffolds within innate immunity. We propose that future antiviral strategies should focus on unmasking viral RNA, thereby restoring its detection by the host innate immune system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.